We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
58 hedge funds and large institutions have $269M invested in Flexion Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
32% more funds holding
Funds holding: 44 → 58 (+14)
13% more capital invested
Capital invested by funds: $238M → $269M (+$31.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
58
Holders Change
+14
Holders Change %
+31.82%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
22
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$16.6M |
| 2 |
Jennison Associates
New York
|
+$5.92M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4.53M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.77M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.91M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.3M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.91M |
| 3 |
DM
Deerfield Management
New York
|
-$2.02M |
| 4 |
VAM
Visium Asset Management
New York
|
-$1.83M |
| 5 |
BC
Broadfin Capital
New York
|
-$1.51M |
